OBJECTIVE: For para- and intraspinal tumors, precise spinal cord delineation is critical for CyberKnife (Accuray, Inc., Sunnyvale, CA) stereotactic radiotherapy. We evaluated whether computed tomographic (CT) myelography is superior to magnetic resonance imaging (MRI) for accurate spinal cord delineation. Treatment parameters and short-term outcome and toxicity are also presented. METHODS: The planning CT scan, the gadolinium-enhanced, T1-weighted, 3-dimensional (3D) fast imaging employing steady-state acquisition MRI scan, and the CT myelogram were fused before volume-of-interest delineation. The planning target volume margin was less than 1 mm using the Xsight Spine tracking system (Accuray). We present data from 11 heavily pretreated patients who underwent CyberKnife stereotactic radiosurgery between November 2006 and January 2008. RESULTS: Spatial resolution was 0.46 and 0.93 mm/pixel for CT myelography and 3D-fast imaging employing steady-state acquisition MRI, respectively. The contrast between cerebrospinal fluid and spinal cord was excellent with CT myelography. A transient postmyelography headache occurred in 1 patient. The mean gross tumor volume was 51.1 mL. The mean prescribed dose was 34 Gy in 4 fractions (range, 2-7 fractions) with 147 beams (range, 79-232 beams) to the 75% reference isodose line (range, 68-80%), covering 95% (range, 86-99%) of the gross tumor volume with a mean conformity index of 1.4 (range, 1.1-1.8). No short-term toxicity on the spinal cord was noted at 1- to 6-months of follow-up. CONCLUSION: CT myelography was more accurate for spinal cord delineation than 3D-fast imaging employing steady-state acquisition MRI (used for its myelographic effect), particularly in the presence of ferromagnetic artifacts in heavily pretreated patients or in patients with severe spinal compression. Because other MRI sequences (T2 and gadolinium-enhanced T1) provide excellent tumor characterization, we suggest trimodality imaging for spinal tumor treatment to yield submillimetric delineation accuracy. Combined with CyberKnife technology, CT myelography can improve the feasibility of dose escalation or reirradiation of spinal tumors in selected patients, thereby increasing local control while avoiding myelopathy. Further follow-up and prospective studies are warranted.
OBJECTIVE: For para- and intraspinal tumors, precise spinal cord delineation is critical for CyberKnife (Accuray, Inc., Sunnyvale, CA) stereotactic radiotherapy. We evaluated whether computed tomographic (CT) myelography is superior to magnetic resonance imaging (MRI) for accurate spinal cord delineation. Treatment parameters and short-term outcome and toxicity are also presented. METHODS: The planning CT scan, the gadolinium-enhanced, T1-weighted, 3-dimensional (3D) fast imaging employing steady-state acquisition MRI scan, and the CT myelogram were fused before volume-of-interest delineation. The planning target volume margin was less than 1 mm using the Xsight Spine tracking system (Accuray). We present data from 11 heavily pretreated patients who underwent CyberKnife stereotactic radiosurgery between November 2006 and January 2008. RESULTS: Spatial resolution was 0.46 and 0.93 mm/pixel for CT myelography and 3D-fast imaging employing steady-state acquisition MRI, respectively. The contrast between cerebrospinal fluid and spinal cord was excellent with CT myelography. A transient postmyelography headache occurred in 1 patient. The mean gross tumor volume was 51.1 mL. The mean prescribed dose was 34 Gy in 4 fractions (range, 2-7 fractions) with 147 beams (range, 79-232 beams) to the 75% reference isodose line (range, 68-80%), covering 95% (range, 86-99%) of the gross tumor volume with a mean conformity index of 1.4 (range, 1.1-1.8). No short-term toxicity on the spinal cord was noted at 1- to 6-months of follow-up. CONCLUSION: CT myelography was more accurate for spinal cord delineation than 3D-fast imaging employing steady-state acquisition MRI (used for its myelographic effect), particularly in the presence of ferromagnetic artifacts in heavily pretreated patients or in patients with severe spinal compression. Because other MRI sequences (T2 and gadolinium-enhanced T1) provide excellent tumor characterization, we suggest trimodality imaging for spinal tumor treatment to yield submillimetric delineation accuracy. Combined with CyberKnife technology, CT myelography can improve the feasibility of dose escalation or reirradiation of spinal tumors in selected patients, thereby increasing local control while avoiding myelopathy. Further follow-up and prospective studies are warranted.
Authors: D Michael Lovelock; Zhigang Zhang; Andrew Jackson; Jennifer Keam; Justin Bekelman; Mark Bilsky; Eric Lis; Yoshiya Yamada Journal: Int J Radiat Oncol Biol Phys Date: 2010-03-28 Impact factor: 7.038
Authors: Giuseppe Roberto D'Agostino; Rosa Autorino; Angelo Pompucci; Maria Carmen De Santis; Stefania Manfrida; Giuseppe Di Lella; Giovanna Mantini; Vincenzo Frascino; Silvia Chiesa; Alessio Albanese; Nicola Dinapoli; Luigi Azario; Alba Fiorentino; Vincenzo Valentini; Carmelo Anile; Mario Balducci Journal: Strahlenther Onkol Date: 2011-06-28 Impact factor: 3.621
Authors: Sangkyu Lee; Dale Michael Lovelock; Alex Kowalski; Kate Chapman; Robert Foley; Mary Gil; Gerri Pastrana; Daniel S Higginson; Yoshiya Yamada; Lei Zhang; James Mechalakos; Ellen Yorke Journal: J Appl Clin Med Phys Date: 2021-10-28 Impact factor: 2.102
Authors: Maria A Schmidt; Rafal Panek; Ruth Colgan; Julie Hughes; Aslam Sohaib; Frank Saran; Julia Murray; Jason Bernard; Patrick Revell; Mathias Nittka; Martin O Leach; Vibeke N Hansen Journal: Radiother Oncol Date: 2016-05-21 Impact factor: 6.280